Atlas Trials

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

Clinical trial NCT00307632 · COMPLETED

Trial details

NCT number
NCT00307632
Sponsor
Janssen-Cilag Farmaceutica Ltda.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Contraception
Start date
2003-02-01
Primary completion
2004-12-01
Enrollment
580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.